Oak Grove Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Oak Grove Capital's LLY Position: Q2 2026 in Review
Oak Grove Capital increased its Eli Lilly (LLY) stake by 19% in Q2 2026, buying an estimated $3.98M and bringing the position to 24,336 shares worth $29.2M. The position accounts for 1.39% of the portfolio, ranked #15.
Oak Grove Capital first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. The position peaked at $78M in Q3 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Oak Grove Capital held 24,336 shares of Eli Lilly worth $29.2M as of Q2 2026.
- Oak Grove Capital bought 3,895 Eli Lilly shares in Q2 2026, an estimated $3.98M.
- Eli Lilly made up 1.39% of Oak Grove Capital's portfolio in Q2 2026, its #15 holding.
- Oak Grove Capital first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
- Oak Grove Capital's Eli Lilly position peaked at $78M in Q3 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Oak Grove Capital's 13F filing for Q2 2026, filed 13 Aug 2026.